NavGeneral InfoEmail Print Original or alternative title Étude De Séroprévalence Des Anti-Sras-Cov-2 Chez Les Donneurs De Sang D’héma-Québec, Vers La Fin De La Première Vague De Covid-19 Provider Hema-Quebec (Canada)Tabulations only Geography Canada (CAN) Québec Coverage type Subnational Time period covered 05/2020 - 07/2020 Series or system Canada - Quebec SARS-CoV-2 Antibody Seroprevalence Study Data type Survey: Epi surveillance Summary This seroprevalence survey was conducted after the first wave of COVID-19 by Hema-Quebec to estimate the percentage of people who contracted the virus. The sample included 7,691 people aged 18 to 69 who donated blood, between May 25 and July 9. The percentage of blood donors infected with the COVID-19 virus was 2.23%. Keywords Blood tests, COVID-19, Disease outbreaks, Incidence, Medical tests, Prevalence Citation Contributors Hema-Quebec (Canada) Quebec National Institute of Public Health (Canada) Publisher Hema-Quebec (Canada) Suggested citation Hema-Quebec (Canada), Quebec National Institute of Public Health (Canada). Canada - Quebec COVID-19 First Wave Blood Donor Seroprevalence Study 2020. Canada: Hema-Quebec (Canada). GHDx Entry last modified on: May 12, 2022